USA FINANCIAL FORMULAS - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 5 filers reported holding HAEMONETICS CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
USA FINANCIAL FORMULAS ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$28,128
+5.2%
3140.0%0.04%
+2.4%
Q2 2023$26,734
-0.6%
314
-3.4%
0.04%
-6.8%
Q1 2023$26,894
-70.4%
325
-73.6%
0.04%
-69.2%
Q3 2022$91,000
-68.4%
1,232
-61.6%
0.14%
+95.9%
Q3 2018$288,0003,2060.07%
Other shareholders
HAEMONETICS CORP shareholders Q4 2023
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders